Corcept Therapeutics | CORT - Zinsaufwendungen Für Schuld





Zinsaufwendungen Für Schuld Veränderung Datum
Acadia Pharmaceuticals USD 0 4.12M 2024-09
Alaunos Therapeutics USD 1.07M 215K 2023-06
ANI Pharmaceuticals USD 3.64M 775K 2026-06
Ardelyx USD 5.6M 160K 2026-03
Aurora Cannabis CAD 230K 1.88M 2026-03
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Bristol-Myers Squibb USD 407M 4M 2026-06
Canopy Growth CAD 12.31M 4.97M 2026-03
Corcept Therapeutics USD 888.7M 73.82M 2026-06
Eli Lilly USD 114.7M 134.3M 2025-09
J&J USD 43M 25M 2026-03
Knight Therapeutics CAD 3.92M 1.56M 2025-12
Lexicon Pharmaceuticals USD 2.03M 124K 2025-12
Merck USD 525M 46M 2026-06
Nektar Therapeutics USD 7.94M 1.83M 2026-03
Novartis USD 462M 119M 2026-06
Novartis USD 281M 8M 2025-09
Omeros USD 4.05M 5.16M 2024-09
Pacira USD 3.62M 77K 2026-06
Pfizer USD 667M 4M 2026-06
Supernus Pharmaceuticals USD 910K 278K 2023-06
TG Therapeutics USD 16.57M 8.91M 2026-06